Stockscreener 앱 받기
206.23
1.01%
-2.11
시간 외 거래:
206.23
전일 마감가:
$208.34
열려 있는:
$208.365
하루 거래량:
6.99M
Relative Volume:
1.05
시가총액:
$364.65B
수익:
$61.16B
순이익/손실:
$4.19B
주가수익비율:
87.33
EPS:
2.3614
순현금흐름:
$17.82B
1주 성능:
-8.49%
1개월 성능:
-8.08%
6개월 성능:
-7.30%
1년 성능:
-2.84%
1일 변동 폭
$204.30
$210.43
1주일 범위
$204.30
$228.62
52주 변동 폭
$164.39
$244.81
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
206.23 | 368.38B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
LLY
Lilly Eli Co
|
917.50 | 819.81B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
237.60 | 571.52B | 94.19B | 26.80B | 19.70B | 11.05 |
|
AZN
Astrazeneca Plc
|
188.93 | 292.21B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
148.19 | 285.86B | 54.72B | 14.02B | 15.32B | 7.1855 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
Buy Or Fear AbbVie Stock At $210? - Forbes
What’s Happening With AbbVie Stock? - Trefis
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
Stillwater Wealth Management Group Takes Position in AbbVie Inc. $ABBV - MarketBeat
Groupama Asset Managment Purchases 10,854 Shares of AbbVie Inc. $ABBV - MarketBeat
Investment Research Partners LLC Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by CIBC Private Wealth Group LLC - MarketBeat
243,718 Shares in AbbVie Inc. $ABBV Bought by CIBC Bancorp USA Inc. - MarketBeat
Centaurus Financial Inc. Has $3.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Allworth Financial LP Acquires 30,124 Shares of AbbVie Inc. $ABBV - MarketBeat
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Stock (ISIN: US00287Y1091) Faces Pressure Amid Recent Pullback: Key Drivers and Investor - AD HOC NEWS
Assessing AbbVie (ABBV) Valuation After The Recent Share Price Pullback - Yahoo Finance
What's Going On With AbbVie Stock Today?AbbVie (NYSE:ABBV) - Benzinga
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Trading Down 5.1%Here's Why - MarketBeat
AbbVie (ABBV) Stock Drops 5% After FDA Approves J&J’s Competing Psoriasis Drug - CoinCentral
AbbVie (ABBV) Faces New Competition from J&J's Icotyde Approval - GuruFocus
AbbVie Inc. (ABBV) is attracting investor attention: Here is what you should know - MSN
J&J’s psoriasis pill to rival AbbVie’s Skyrizi (JNJ:NYSE) - Seeking Alpha
AbbVie (ABBV) slides as investors weigh policy-related pricing risk and recent financing activity - Quiver Quantitative
What triggered AbbVie shares' latest price pullback - Traders Union
AbbVie, Philip Morris among market cap stock movers on Wednesday - Investing.com
Weak momentum, oversold signals: AbbVie stock slides 3.70% - Traders Union
AbbVie Inc Stock (ABBV) Moved Down by 4.60% on Mar 18: A Full Analysis - TradingKey
AbbVie Stock: EPS Set to Jump 45% in 2026 as Skyrizi and Rinvoq Dominate IBD - TIKR.com
AbbVie Inc. $ABBV Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sunbelt Securities Inc. - MarketBeat
Danske Bank A S Invests $279.61 Million in AbbVie Inc. $ABBV - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Has $31.89 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Captrust Financial Advisors Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Balances False Claims Act Risks With Alloy Antibody Collaboration - simplywall.st
Advisory Services Network LLC Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
ABBV Stock Quote Price and Forecast - CNN
AbbVie Inc. (ABBV): Billionaire Ken Fisher admires this pharma stock - MSN
AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock - Insider Monkey
AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? - TradingView
Alloy Therapeutics and Abbvie partner on antibody platform - BioWorld MedTech
AbbVie Inc. $ABBV Shares Purchased by Mirabella Financial Services LLP - MarketBeat
Mariner LLC Purchases 175,406 Shares of AbbVie Inc. $ABBV - MarketBeat
US FDA declines to approve Aldeyra's eye disorder drug, shares slump - Reuters
Morse Asset Management Inc Grows Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Trimmed by Mercer Global Advisors Inc. ADV - MarketBeat
AbbVie price tries to vent off oversold saturationForecast today17-03-2026 - Economies.com
Mirabella Financial Services LLP Buys 19,980 Shares of AbbVie Inc. $ABBV - MarketBeat
Moore Capital Management LP Sells 40,000 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Decreased by L2 Asset Management LLC - MarketBeat
AbbVie (ABBV) Partners with Alloy Therapeutics for Advanced Anti - GuruFocus
Alloy Therapeutics agreement with AbbVie to develop a new antibody platform - marketscreener.com
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
1.08%
자본화:
|
볼륨(24시간):